132nd MAINE LEGISLATURE
FIRST REGULAR SESSION-2025
Legislative Document No. 710
H.P. 449 House of Representatives, February 25, 2025
An Act to Expand Access and Reduce Barriers to Access to
Naloxone Hydrochloride and Other Opioid Overdose-reversing
Medications
Submitted by the Department of Health and Human Services pursuant to Joint Rule 204.
Received by the Clerk of the House on February 20, 2025. Referred to the Committee on
Health and Human Services pursuant to Joint Rule 308.2 and ordered printed pursuant to Joint
Rule 401.
ROBERT B. HUNT
Clerk
Presented by Representative ZAGER of Portland.
Printed on recycled paper

1 Be it enacted by the People of the State of Maine as follows:
2 Sec. 1. 22 MRSA §2353, sub-§4, as amended by PL 2023, c. 71, §1 and c. 161, §3,
3 is further amended to read:
4 4. Community-based drug overdose prevention programs; standing orders for
5 naloxone hydrochloride or another opioid overdose-reversing medication. Acting
6 under standing orders from a licensed health care professional authorized by law to
7 prescribe naloxone hydrochloride or another opioid overdose-reversing medication, a
8 public health an agency that provides services to populations at high risk for a drug
9 overdose may establish an overdose prevention program in accordance with rules adopted
10 by the department and the provisions of this subsection.
11 A. Notwithstanding any provision of law to the contrary, an overdose prevention
12 program established under this subsection may store and dispense naloxone
13 hydrochloride or another opioid overdose-reversing medication without being subject
14 to the provisions of Title 32, chapter 117 as long as these activities are undertaken
15 without charge or compensation.
16 B. An overdose prevention program established under this subsection may distribute
17 unit-of-use packages of naloxone hydrochloride or another opioid overdose-reversing
18 medication and the medical supplies necessary to administer the naloxone
19 hydrochloride or another opioid overdose-reversing medication to a person who has
20 successfully completed training provided by the overdose prevention program that
21 meets the protocols and criteria established by the department, so that the person may
22 possess and administer naloxone hydrochloride or another opioid overdose-reversing
23 medication to an individual who appears to be experiencing an opioid-related drug
24 overdose.
25 C. With the express consent of a municipality, an overdose prevention program
26 established under this subsection may provide and maintain naloxone hydrochloride or
27 another opioid overdose-reversing medication in a wall-mounted box or other visible
28 and accessible container, including, but not limited to, a vending machine, on publicly
29 accessible property of the municipality, including a municipal building, public
30 restroom, public library or public park or recreational facility, for use by a member of
31 the public in response to an opioid-related drug overdose.
32 The department shall adopt rules to implement this subsection. Rules adopted pursuant to
33 this subsection are routine technical rules as defined in Title 5, chapter 375, subchapter
34 2‑A.
35 Sec. 2. 22 MRSA §2353, sub-§4-A, ¶B, as amended by PL 2023, c. 161, §3, is
36 repealed.
37 Sec. 3. 22 MRSA §2353, sub-§4-A, ¶C, as amended by PL 2023, c. 161, §3, is
38 further amended to read:
39 C. A licensed health care professional authorized by law to prescribe naloxone
40 hydrochloride or another opioid overdose-reversing medication shall distribute unit-
41 of-use packages of naloxone hydrochloride or another opioid overdose-reversing
42 medication and any medical supplies necessary to administer the naloxone
43 hydrochloride or another opioid overdose-reversing medication to a recovery residence
Page 1 - 132LR0267(01)

414 that has provided training described in paragraph B so that the recovery residence may
425 possess and administer naloxone hydrochloride or another opioid overdose-reversing
436 medication to an individual who appears to be experiencing a drug-related overdose.
4 Sec. 4. 22 MRSA §2353, sub-§5, ¶C, as enacted by PL 2023, c. 71, §2, is amended
5 to read:
6 C. A municipality or overdose prevention program is immune from criminal and civil
7 liability for providing or maintaining naloxone hydrochloride containers or containers
8 of another opioid overdose-reversing medication under subsection 4, paragraph C.
9 Sec. 5. 22 MRSA §2353, sub-§5, ¶D, as enacted by PL 2023, c. 154, §2, is
10 amended to read:
11 D. A person not described in this section as being authorized to possess, obtain, store,
12 administer or dispense naloxone hydrochloride or another opioid overdose-reversing
13 medication or a person, notwithstanding any provision of law to the contrary, acting in
14 good faith and with reasonable care, is immune from criminal and civil liability and is
15 not subject to professional or other disciplinary action for providing to another person
16 naloxone hydrochloride or another opioid overdose-reversing medication, or for
17 administering naloxone hydrochloride or another opioid overdose-reversing
18 medication to an individual whom the person believes in good faith is experiencing an
19 opioid-related drug overdose or for any outcome resulting from such actions.
20 SUMMARY
2211 This bill amends the laws governing the requirements for access to and distribution of
2222 naloxone hydrochloride or other opioid overdose-reversing medications. The bill removes
2233 training requirements for community-based drug overdose prevention programs and
2244 recovery residences and expands access by allowing municipalities to provide vending
2255 machines for use by the public in response to an opioid-related drug overdose. The bill
2266 further provides additional immunity protections for all persons who may administer
2277 naloxone hydrochloride or another opioid overdose-reversing medication to another
2288 individual in good faith when they believe the other individual is experiencing an opioid-
2299 related drug overdose. Lastly, the bill incorporates other opioid overdose-reversing
3300 medications in the provisions governing naloxone hydrochloride.
Page 2 - 132LR0267(01)

[DELETED: tN9H]
[DELETED: B i4nu s o f a l h c p a b l tp n h o a o o m ap h a a t p s t p a h r f a do0b1A2p e u t s m s a d n3h4t5w6B7u8m a t m s n t a t n9h0s1m2p3m4o5C  W t e c o a m a o p p6e7a8a9a p o t m i a m b p0r1t2T3t425 6r7 8f9C  A l h c p a b l t p n0h1o p o n h o a o o2m a a m s n t a t n3h]
[DELETED: 4t5p6m tClo 0a1D2a3m4g5n6n h o a o o m o f7a n h o a o o8m9o1T2n3t r f c d o p p a4r5m6f p a i p f a p w m a7n h o a o o m t a8i9r d o L t b i o o o0m]